January 2017 FDA Recall Drug by Vistapharm, Inc.
D-0469-2017 - Defective Container

This Class II drug recall was voluntarily initiated by Vistapharm, Inc. on January 18, 2017 for the product Drug. The FDA reported the reason for recall as defective container. The product was distributed in Domestic: AL, AZ, CA, CO, CT, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NY, OH, OK, OR, PA, TN, TX, UT, VA, WA WI, & WV. and the recall is currently terminated.

Recall Number: D-0469-2017

Reason for Recall
Defective Container: Leakage of unit dose cups that may occur at the seal.
Initiated
01-18-2017
Reported
02-15-2017
Quantity
13,609 cases

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Domestic: AL, AZ, CA, CO, CT, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NY, OH, OK, OR, PA, TN, TX, UT, VA, WA WI, & WV.
Potassium Chloride Oral Solution, USP, 10%, 20 mEq per 15 mL, packaged in 15 mL unit dose cups (NDC 66689-047-01), 50 unit dose cups per case (NDC 66689-047-50), Rx only, Xact Dose, Manufactured by VistaPharm, Largo, FL 33771.

Batch or Lot Expiration Information

Lot# 's: 437600, Exp 07/17; 447100, Exp 10/17